Spinout Active LTD

Company profile

Erebagen Ltd

ErebaGen Chemistry from Nature

Erebagen Ltd is a UK company with status active founded in 2020 based in South East England.

CRN
12537588
Founded
2020
Age
6

Overview

Browse spinouts
Legal name
EREBAGEN LTD
Region
South East England
Registered address
CIE BUILDING BEGBROKE HILL
YARNTON
KIDLINGTON
OXFORDSHIRE
ENGLAND
OX5 1PF
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
2

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Dec
2027

Accounts due

Accounts Due

Next accounts due date

12 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2026

Accounts filed

Accounts

Last accounts made up date

29 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Mar
2020

Incorporated

Inception

Company registered at Companies House

Spinout profile

6 entries

Company description

Natural product pathway bioengineering

Erebagen develops software that uses bioinformatics to discover compounds for pharmaceuticals development.

Our innovation enables us to engineer soil bacteria to produce new bioactive natural product compounds with hit rates 20x-better than synthetic chemicals and create structural variants of bioactive molecules. Our developed platform has applications in several sectors including pharmaceutical and agrochemical - to discover and develop new natural products into new medicines and crop protection compounds.

Project impact

Has identified five early-adopters through ICURe.

2 FTE scientific post currently in the company.

1 FTE scientific post currently in the company.

Public funding

3 awards
First funded
2021
Funded years
2021, 2025, 2026
Age at first award
1 years

Projects

2026 Grant for R&D Lead participant

Enhancing Enzyme Quality and Yield to Unlock Sustainable Biocatalytic Nitration

1 Feb 2026 to 31 Jul 2026

Awarded
£14,814
Total cost £14,814

Our project, Novel Biocatalysts for Sustainable Manufacture of Pharmaceuticals, is developing a greener, safer way to produce important pharmaceutical chemicals. Traditional chemical processes for adding nitro groups to molecules require harsh conditions and generate hazardous waste. We are replacing these methods with enzymes called nitrating cytochrome ...

2025 Collaborative R&D Lead participant

Novel Biocatalysts for Sustainable Manufacture of Pharmaceuticals

1 Mar 2025 to 28 Feb 2027

Awarded
£866,314
Total cost £1,237,591

ErebaGen harnesses chemistry from Nature and its project aims to transform hazardous chemical manufacture through the use of sustainable biological processes. The innovation focus and need is aromatic nitration, a critical chemical step in production of numerous pharmaceutical intermediates. This reaction proceeds rapidly, generates heat, can get out of c...

2021 Study Lead participant

Genetics to new chemical entities

1 Sep 2021 to 30 Sep 2023

Awarded
£209,833
Total cost £299,762

Resistant strains of bacteria, fungi and plants that are not susceptible to modern medicine and crop protection chemicals, pose a serious threat to society. The rise in antibiotic resistant superbugs, drug-resistant cancers and treatment-resistant crop pests are all threatening to have a major impact on our health, quality of life and ultimately the susta...

Product types

Collaborative R&D Grant for R&D Study